Janus Henderson Group
ISEE

Janus Henderson Group’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Janus Henderson Group’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-156,831
Closed -$6.17M – 2634
2023
Q2 		$6.17M Sell
156,831
-4,530,378
-97% -$160M ﹤0.01% 803
2023
Q1 		$114M Buy
4,687,209
+133,305
+3% +$2.92M 0.08% 231
2022
Q4 		$97.5M Sell
4,553,904
-5,673,078
-55% -$121M 0.07% 241
2022
Q3 		$183M Buy
10,226,982
+2,077,263
+25% +$27.3M 0.07% 248
2022
Q2 		$78.4M Buy
8,149,719
+6,704,654
+464% +$84.2M 0.05% 295
2022
Q1 		$24.3M Buy
1,445,065
+1,433,850
+12,785% +$21.2M 0.01% 703
2021
Q4 		$188K Buy
+11,215
New +$184K ﹤0.01% 2410

Janus Henderson Group's ISEE Position: Q3 2023 in Review

Janus Henderson Group sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 156,831 shares — an estimated $6.17M sold.

Janus Henderson Group first reported a position in ISEE in Q4 2021 and held it in 7 quarters. The position peaked at $183M in Q3 2022. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Janus Henderson Group reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Janus Henderson Group sold 156,831 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $6.17M.
  • Janus Henderson Group first reported a position in IVERIC bio, Inc. Common Stock in Q4 2021 and held it in 7 quarters.
  • Janus Henderson Group's IVERIC bio, Inc. Common Stock position peaked at $183M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Janus Henderson Group's 13F filing for Q3 2023, filed 14 Nov 2023.